Chemoprävention des prostatakarzinoms

Translated title of the contribution: Chemoprevention of prostate cancer

B. Djavan, I. Thompson, M. S. Michel, M. Waldert, C. Seitz

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Despite advances in the detection and management of prostate cancer, this disease remains a major cause of morbidity and mortality in men. Increasing attention has focused on the role of chemoprevention for prostate cancer, i.e., the administration of agents that inhibit one or more steps in the natural course of prostate carcinogenesis. We review prostate cancer chemoprevention studies in Europe. Published studies were identified in a search of MEDLINE. Information about ongoing studies was provided by author access to protocols. A variety of chemoprevention studies have focused on the role of dietary factors, vitamins, and trace elements in prostate cancer. Some of these studies have been prospective, randomized, and double-blinded, while others have used retrospective or epidemiological approaches. Large-scale randomized studies are also evaluating the role of 5α-reductase inhibitors, which inhibit the conversion of testosterone to the more potent androgen dihydrotestosterone. Robust evidence is lacking for the value of chemopreventive agents in prostate cancer. Current evidence does suggest that vitamin E and selenium may have a role in prostate cancer chemoprevention. Data from two studies, one examining the type 1 5α-reductase selective inhibitor finasteride and the other using the dual 5a-reductase inhibitor dutasteride, will determine the benefits of androgen inhibition strategies for prostate cancer chemoprevention.

Original languageGerman
Pages (from-to)557-561
Number of pages5
JournalUrologe - Ausgabe A
Volume43
Issue number5
DOIs
StatePublished - May 2004

Fingerprint

Chemoprevention
Prostatic Neoplasms
Oxidoreductases
Androgens
Finasteride
Dihydrotestosterone
Trace Elements
Selenium
Vitamin E
Vitamins
MEDLINE
Testosterone
Prostate
Carcinogenesis
Morbidity
Mortality

Keywords

  • 5α-Reductase inhibitors
  • Chemoprevention studies
  • Dietary composition
  • Dutasteride
  • Finasteride

ASJC Scopus subject areas

  • Urology

Cite this

Djavan, B., Thompson, I., Michel, M. S., Waldert, M., & Seitz, C. (2004). Chemoprävention des prostatakarzinoms. Urologe - Ausgabe A, 43(5), 557-561. https://doi.org/10.1007/s00120-004-0537-2

Chemoprävention des prostatakarzinoms. / Djavan, B.; Thompson, I.; Michel, M. S.; Waldert, M.; Seitz, C.

In: Urologe - Ausgabe A, Vol. 43, No. 5, 05.2004, p. 557-561.

Research output: Contribution to journalArticle

Djavan, B, Thompson, I, Michel, MS, Waldert, M & Seitz, C 2004, 'Chemoprävention des prostatakarzinoms', Urologe - Ausgabe A, vol. 43, no. 5, pp. 557-561. https://doi.org/10.1007/s00120-004-0537-2
Djavan B, Thompson I, Michel MS, Waldert M, Seitz C. Chemoprävention des prostatakarzinoms. Urologe - Ausgabe A. 2004 May;43(5):557-561. https://doi.org/10.1007/s00120-004-0537-2
Djavan, B. ; Thompson, I. ; Michel, M. S. ; Waldert, M. ; Seitz, C. / Chemoprävention des prostatakarzinoms. In: Urologe - Ausgabe A. 2004 ; Vol. 43, No. 5. pp. 557-561.
@article{12161a2056d74b89b93a1d1b52c5c60a,
title = "Chemopr{\"a}vention des prostatakarzinoms",
abstract = "Despite advances in the detection and management of prostate cancer, this disease remains a major cause of morbidity and mortality in men. Increasing attention has focused on the role of chemoprevention for prostate cancer, i.e., the administration of agents that inhibit one or more steps in the natural course of prostate carcinogenesis. We review prostate cancer chemoprevention studies in Europe. Published studies were identified in a search of MEDLINE. Information about ongoing studies was provided by author access to protocols. A variety of chemoprevention studies have focused on the role of dietary factors, vitamins, and trace elements in prostate cancer. Some of these studies have been prospective, randomized, and double-blinded, while others have used retrospective or epidemiological approaches. Large-scale randomized studies are also evaluating the role of 5α-reductase inhibitors, which inhibit the conversion of testosterone to the more potent androgen dihydrotestosterone. Robust evidence is lacking for the value of chemopreventive agents in prostate cancer. Current evidence does suggest that vitamin E and selenium may have a role in prostate cancer chemoprevention. Data from two studies, one examining the type 1 5α-reductase selective inhibitor finasteride and the other using the dual 5a-reductase inhibitor dutasteride, will determine the benefits of androgen inhibition strategies for prostate cancer chemoprevention.",
keywords = "5α-Reductase inhibitors, Chemoprevention studies, Dietary composition, Dutasteride, Finasteride",
author = "B. Djavan and I. Thompson and Michel, {M. S.} and M. Waldert and C. Seitz",
year = "2004",
month = "5",
doi = "10.1007/s00120-004-0537-2",
language = "German",
volume = "43",
pages = "557--561",
journal = "Der Urologe",
issn = "0340-2592",
publisher = "Springer Verlag",
number = "5",

}

TY - JOUR

T1 - Chemoprävention des prostatakarzinoms

AU - Djavan, B.

AU - Thompson, I.

AU - Michel, M. S.

AU - Waldert, M.

AU - Seitz, C.

PY - 2004/5

Y1 - 2004/5

N2 - Despite advances in the detection and management of prostate cancer, this disease remains a major cause of morbidity and mortality in men. Increasing attention has focused on the role of chemoprevention for prostate cancer, i.e., the administration of agents that inhibit one or more steps in the natural course of prostate carcinogenesis. We review prostate cancer chemoprevention studies in Europe. Published studies were identified in a search of MEDLINE. Information about ongoing studies was provided by author access to protocols. A variety of chemoprevention studies have focused on the role of dietary factors, vitamins, and trace elements in prostate cancer. Some of these studies have been prospective, randomized, and double-blinded, while others have used retrospective or epidemiological approaches. Large-scale randomized studies are also evaluating the role of 5α-reductase inhibitors, which inhibit the conversion of testosterone to the more potent androgen dihydrotestosterone. Robust evidence is lacking for the value of chemopreventive agents in prostate cancer. Current evidence does suggest that vitamin E and selenium may have a role in prostate cancer chemoprevention. Data from two studies, one examining the type 1 5α-reductase selective inhibitor finasteride and the other using the dual 5a-reductase inhibitor dutasteride, will determine the benefits of androgen inhibition strategies for prostate cancer chemoprevention.

AB - Despite advances in the detection and management of prostate cancer, this disease remains a major cause of morbidity and mortality in men. Increasing attention has focused on the role of chemoprevention for prostate cancer, i.e., the administration of agents that inhibit one or more steps in the natural course of prostate carcinogenesis. We review prostate cancer chemoprevention studies in Europe. Published studies were identified in a search of MEDLINE. Information about ongoing studies was provided by author access to protocols. A variety of chemoprevention studies have focused on the role of dietary factors, vitamins, and trace elements in prostate cancer. Some of these studies have been prospective, randomized, and double-blinded, while others have used retrospective or epidemiological approaches. Large-scale randomized studies are also evaluating the role of 5α-reductase inhibitors, which inhibit the conversion of testosterone to the more potent androgen dihydrotestosterone. Robust evidence is lacking for the value of chemopreventive agents in prostate cancer. Current evidence does suggest that vitamin E and selenium may have a role in prostate cancer chemoprevention. Data from two studies, one examining the type 1 5α-reductase selective inhibitor finasteride and the other using the dual 5a-reductase inhibitor dutasteride, will determine the benefits of androgen inhibition strategies for prostate cancer chemoprevention.

KW - 5α-Reductase inhibitors

KW - Chemoprevention studies

KW - Dietary composition

KW - Dutasteride

KW - Finasteride

UR - http://www.scopus.com/inward/record.url?scp=2942618589&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2942618589&partnerID=8YFLogxK

U2 - 10.1007/s00120-004-0537-2

DO - 10.1007/s00120-004-0537-2

M3 - Article

VL - 43

SP - 557

EP - 561

JO - Der Urologe

JF - Der Urologe

SN - 0340-2592

IS - 5

ER -